Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioCircuit's Nerve Tape Earns FDA Nod - Orthopedic Design & Technology
OEM News

BioCircuit’s Nerve Tape Earns FDA Nod

First ever sutureless solution for surgical repair of transected nerves.

BioCircuit Technologies, an NIH-funded company focused on tissue repair and neuromodulation, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Nerve Tape nerve repair device.
 
According to the company, Nerve Tape is the first FDA-cleared, sutureless tool to surgically repair transected nerves.
 
“The development and clearance of Nerve Tape represents a significant advancement in the treatment of nerve injuries,” Jonathan Isaacs, MD, Professor and Chair, Division of Hand Surgery, Virginia Commonwealth University Medical Center, told the press. “This product has the potential to offer surgeons a faster, simpler method for achieving a precise, reliable repair of injured nerves. As a co-inventor with several years of experience using the device in animal models, I look forward to having Nerve Tape available for clinical use.” 
 
“We are very pleased to have completed this critical milestone on our path towards providing a new solution for the treatment of peripheral nerve injuries,” added Michelle Jarrard, CEO of BioCircuit Technologies. “As BioCircuit’s first FDA cleared medical device, Nerve Tape exemplifies our commitment to equipping surgeons with powerful, practical tools to improve the treatment of injuries, and we are excited to be entering the commercial phase of development as we prepare to bring this solution to market.”
 
The technology was co-developed with the Orthopedic Microsurgery Laboratory at Virginia Commonwealth University. BioCircuit is working with supply partners to prepare Nerve Tape’s U.S. launch. The company expects it to be commercially available for first human use in 2023.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters